Biotricity, Inc. Stock price

Equities

BTCY

US09074H2031

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
1.48 USD +8.82% Intraday chart for Biotricity, Inc. +4.23% +28.70%
Sales 2024 * 12M Sales 2025 * 14.3M Capitalization 14.01M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.17 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.98 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 55
Yield 2024 *
-
Yield 2025 *
-
Free-Float 83.22%
More Fundamentals * Assessed data
Dynamic Chart
1 day+8.82%
1 week+4.23%
Current month+48.00%
1 month+60.83%
3 months+21.31%
6 months-29.86%
Current year+28.70%
More quotes
1 week
1.12
Extreme 1.12
1.55
1 month
0.90
Extreme 0.9
1.67
Current year
0.72
Extreme 0.7249
1.67
1 year
0.70
Extreme 0.7007
5.10
3 years
0.70
Extreme 0.7007
31.80
5 years
0.70
Extreme 0.7007
31.80
10 years
0.70
Extreme 0.7007
117.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 39 12-08-28
Director of Finance/CFO 57 17-10-26
Chief Tech/Sci/R&D Officer - 16-04-30
Members of the board TitleAgeSince
Director/Board Member 65 22-05-03
Director/Board Member 59 22-08-10
Director/Board Member 59 16-05-02
More insiders
Date Price Change Volume
24-03-28 1.48 +8.82% 25,785
24-03-27 1.36 +2.26% 17,392
24-03-26 1.33 +4.72% 26,438
24-03-25 1.27 -9.29% 57,357
24-03-22 1.4 -1.41% 59,619

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.48
Average target price
-
Consensus
  1. Stock
  2. Equities
  3. Stock Biotricity, Inc. - Nasdaq